dapsone has been researched along with Angiitis in 42 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "ARAMIS is a multicenter, sequential, multiple assignment randomized trial with an enrichment design (SMARTER) aimed at comparing the efficacy of three drugs-azathioprine, colchicine, and dapsone-commonly used to treat various forms of isolated skin vasculitis." | 9.34 | Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone. ( Borchin, R; Grayson, PC; Krischer, JP; McAlear, CA; Merkel, PA; Micheletti, RG; Pagnoux, C; Tamura, RN, 2020) |
| "Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders." | 7.75 | Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009) |
| " We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone." | 7.68 | Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990) |
| "Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus." | 7.66 | Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 6.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| "ARAMIS is a multicenter, sequential, multiple assignment randomized trial with an enrichment design (SMARTER) aimed at comparing the efficacy of three drugs-azathioprine, colchicine, and dapsone-commonly used to treat various forms of isolated skin vasculitis." | 5.34 | Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone. ( Borchin, R; Grayson, PC; Krischer, JP; McAlear, CA; Merkel, PA; Micheletti, RG; Pagnoux, C; Tamura, RN, 2020) |
| "Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders." | 3.75 | Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009) |
| " We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone." | 3.68 | Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990) |
| "Dapsone therapy for leukocytoclastic (necrotizing) vasculitis has been little used, except for the variant forms of erythema elevatum diutinum and urticarial vasculitis." | 3.67 | Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. ( Fredenberg, MF; Malkinson, FD, 1987) |
| "Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus." | 3.66 | Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 2.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| "Advances in the diagnosis and treatment of vasculitis will also be discussed." | 2.38 | Immune-complex vasculitis: role of complement and IgG-Fc receptor functions. ( Moore, SE; Smiley, JD, 1989) |
| "Envenomation may induce a generalized exanthem known clinically but not described histologically." | 1.34 | Generalized vasculitic exanthem following Loxosceles reclusa envenomation. ( Boyd, AS; Hayes, BB; Robb, CW, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (26.19) | 18.7374 |
| 1990's | 9 (21.43) | 18.2507 |
| 2000's | 11 (26.19) | 29.6817 |
| 2010's | 8 (19.05) | 24.3611 |
| 2020's | 3 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshida, M | 1 |
| Nambu, R | 1 |
| Yasuda, R | 1 |
| Sakaguchi, H | 1 |
| Hara, T | 1 |
| Iwama, I | 1 |
| Mizuochi, T | 1 |
| Tabata, MM | 1 |
| Lin, WM | 1 |
| Goldstein, J | 1 |
| Quinn, TR | 1 |
| Chen, ST | 1 |
| Ramelli, V | 1 |
| Rinoldi, PO | 1 |
| Bianchetti, MG | 1 |
| Lava, SAG | 1 |
| Ramelli, GP | 1 |
| Milani, GP | 1 |
| Roman, C | 1 |
| Dima, B | 1 |
| Muyshont, L | 1 |
| Schurmans, T | 1 |
| Gilliaux, O | 1 |
| Micheletti, RG | 1 |
| Pagnoux, C | 1 |
| Tamura, RN | 1 |
| Grayson, PC | 1 |
| McAlear, CA | 1 |
| Borchin, R | 1 |
| Krischer, JP | 1 |
| Merkel, PA | 1 |
| Lee, KH | 1 |
| Park, JH | 1 |
| Kim, DH | 1 |
| Hwang, J | 1 |
| Lee, G | 1 |
| Hyun, JS | 1 |
| Heo, ST | 1 |
| Choi, JH | 1 |
| Kim, M | 2 |
| Kim, SI | 1 |
| Eisenhut, M | 1 |
| Kronbichler, A | 1 |
| Shin, JI | 1 |
| Gusdorf, L | 1 |
| Lipsker, D | 1 |
| Yates, M | 1 |
| Loke, YK | 1 |
| Watts, RA | 1 |
| MacGregor, AJ | 1 |
| Christiansen, J | 1 |
| Kahn, R | 1 |
| Schmidtchen, A | 1 |
| Berggård, K | 1 |
| Schulkes, KJ | 1 |
| Tervaert, JW | 1 |
| Rijken, F | 1 |
| Haas, LE | 1 |
| Fujimoto, M | 1 |
| Asano, Y | 1 |
| Ishii, T | 1 |
| Ogawa, F | 1 |
| Kawakami, T | 1 |
| Kodera, M | 1 |
| Abe, M | 1 |
| Isei, T | 1 |
| Ito, T | 1 |
| Inoue, Y | 1 |
| Imafuku, S | 1 |
| Irisawa, R | 1 |
| Ohtsuka, M | 2 |
| Kadono, T | 1 |
| Kawaguchi, M | 1 |
| Kukino, R | 1 |
| Kono, T | 1 |
| Sakai, K | 1 |
| Takahara, M | 1 |
| Tanioka, M | 1 |
| Nakanishi, T | 1 |
| Nakamura, Y | 1 |
| Hashimoto, A | 1 |
| Hasegawa, M | 1 |
| Hayashi, M | 1 |
| Fujiwara, H | 1 |
| Maekawa, T | 1 |
| Matsuo, K | 1 |
| Madokoro, N | 1 |
| Yamasaki, O | 1 |
| Yoshino, Y | 1 |
| Le Pavoux, A | 1 |
| Tachibana, T | 1 |
| Ihn, H | 1 |
| Chun, JS | 1 |
| Yun, SJ | 1 |
| Kim, SJ | 1 |
| Lee, SC | 1 |
| Won, YH | 1 |
| Lee, JB | 1 |
| Francès, C | 1 |
| Barete, S | 1 |
| Ayoub, N | 1 |
| Piette, JC | 1 |
| Seybold, H | 1 |
| Simon, M | 1 |
| Schuler, G | 1 |
| Lüftl, M | 1 |
| Lee, JS | 1 |
| Loh, TH | 1 |
| Seow, SC | 1 |
| Tan, SH | 1 |
| Robb, CW | 1 |
| Hayes, BB | 1 |
| Boyd, AS | 1 |
| Miyachi, Y | 1 |
| Yanase, K | 1 |
| Imamura, S | 1 |
| Niwa, Y | 1 |
| Ruzicka, T | 1 |
| Goerz, G | 1 |
| Valente, RM | 1 |
| Conn, DL | 1 |
| Erdi, H | 1 |
| Anadolu, R | 1 |
| Pişkin, G | 1 |
| Gürgey, E | 1 |
| Lotti, T | 1 |
| Ghersetich, I | 1 |
| Comacchi, C | 1 |
| Jorizzo, JL | 1 |
| Nakajima, H | 1 |
| Ikeda, M | 1 |
| Yamamoto, Y | 1 |
| Kodama, H | 1 |
| Cadnapaphornchai, MA | 1 |
| Saulsbury, FT | 2 |
| Norwood, VF | 1 |
| Hart, MH | 1 |
| Galaria, NA | 1 |
| Junkins-Hopkins, JM | 1 |
| Kligman, D | 1 |
| James, WD | 1 |
| Delgado, J | 1 |
| Gómez-Cerezo, J | 1 |
| Sigüenza, M | 1 |
| Barbado, FJ | 1 |
| Dupond, JL | 1 |
| Vazquez, JJ | 1 |
| Ling, TC | 1 |
| Kendra, JR | 1 |
| Al-Dawoud, A | 1 |
| Coulson, IH | 1 |
| DiCaudo, DJ | 1 |
| Connolly, SM | 1 |
| Tanzer, FR | 1 |
| Lynfield, YL | 1 |
| Dewar, CL | 1 |
| Bellamy, N | 1 |
| González Quijada, S | 1 |
| López Lázaro, L | 1 |
| Reinares García, L | 1 |
| Borregón Carretero, SJ | 1 |
| Sastre Varela, J | 1 |
| Estrada Pérez, V | 1 |
| Barlow, RJ | 1 |
| Schulz, EJ | 1 |
| Joubert, B | 1 |
| Devant, O | 1 |
| Amblard, P | 1 |
| Holtman, JH | 1 |
| Neustadt, DH | 1 |
| Klein, J | 1 |
| Callen, JP | 1 |
| Smiley, JD | 1 |
| Moore, SE | 1 |
| Faulhaber, G | 1 |
| Lechner, W | 1 |
| Bernard, P | 1 |
| Arnaud, M | 1 |
| Treves, R | 1 |
| Bonnetblanc, JM | 1 |
| Fredenberg, MF | 1 |
| Malkinson, FD | 1 |
| Fortson, JS | 1 |
| Zone, JJ | 1 |
| Hammond, ME | 1 |
| Groggel, GC | 1 |
| Frucht, U | 1 |
| Gramm, HJ | 1 |
| Dennhardt, R | 1 |
| Asghar, SS | 1 |
| Westerhof, W | 1 |
| Das, PK | 1 |
| Jansen, FC | 1 |
| Cormane, RH | 1 |
| Muramatsu, C | 1 |
| Tanabe, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Multicenter Study for Isolated Skin Vasculitis[NCT02939573] | Phase 2 | 90 participants (Anticipated) | Interventional | 2017-01-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for dapsone and Angiitis
| Article | Year |
|---|---|
Neutrophilic urticarial dermatosis: A review.
Topics: Arthralgia; Colchicine; Cryopyrin-Associated Periodic Syndromes; Dapsone; Dermis; Diagnosis, Differe | 2018 |
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dap | 2014 |
Current therapies for systemic vasculitis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunization, Passive; | 1994 |
Cutaneous small-vessel vasculitis.
Topics: Aminocaproates; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antigen-Antibody Co | 1998 |
Immune-complex vasculitis: role of complement and IgG-Fc receptor functions.
Topics: Cyclophosphamide; Dapsone; Humans; Immune Complex Diseases; Immunoglobulin G; Methotrexate; Receptor | 1989 |
1 trial available for dapsone and Angiitis
| Article | Year |
|---|---|
Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone.
Topics: Azathioprine; Colchicine; Cross-Over Studies; Dapsone; Drug Resistance; Humans; Multicenter Studies | 2020 |
36 other studies available for dapsone and Angiitis
| Article | Year |
|---|---|
Dapsone for Refractory Gastrointestinal Symptoms in Children With Immunoglobulin A Vasculitis.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Child; Dapsone; Gastrointestinal Diseases; Humans; IgA Vasc | 2022 |
Localised chronic fibrosing vasculitis versus erythema elevatum diutinum.
Topics: Dapsone; Erythema; Female; Fibrosis; Granuloma; Humans; Plasma Cells; Vasculitis; Vasculitis, Leukoc | 2023 |
Dapsone in immunoglobulin A-associated vasculitis.
Topics: Dapsone; Humans; IgA Vasculitis; Immunoglobulin A; Vasculitis; Vasculitis, Leukocytoclastic, Cutaneo | 2019 |
Authors' response to correspondence entitled "Dapsone in immunoglobulin A-associated vasculitis".
Topics: Dapsone; Humans; Immunoglobulin A; Vasculitis | 2019 |
Dapsone as a potential treatment option for Henoch-Schönlein Purpura (HSP).
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Chemotaxis; Cytokines; Dapsone; Free Radicals; Hu | 2017 |
Idiopathic angioedema and urticarial vasculitis in a patient with a history of acquired haemophilia.
Topics: Aged; Angioedema; Autoimmunity; Azathioprine; Colchicine; Dapsone; Drug Therapy, Combination; Hemoph | 2015 |
Dapsone hypersensitivity syndrome not related to G6PD deficiency.
Topics: Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Dapsone; Diagnosis, Differential; Dru | 2015 |
The wound/burn guidelines - 4: Guidelines for the management of skin ulcers associated with connective tissue disease/vasculitis.
Topics: Antithrombins; Calcinosis; Calcium Channel Blockers; Connective Tissue Diseases; Dapsone; Endothelin | 2016 |
Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies.
Topics: Adult; Autoantibodies; Dapsone; Dermatologic Agents; Drug Eruptions; Female; Humans; Hypersensitivit | 2009 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermato | 2003 |
[Refractory cutaneous necrotizing vasculitis. Successful sulfone therapy].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Resistance; Female; Humans; Necrosis; | 2006 |
Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; Blood Vessels; Colchicine; Daps | 2007 |
Generalized vasculitic exanthem following Loxosceles reclusa envenomation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cryotherapy; Dapsone; Drug Therapy, Combi | 2007 |
Increased hydroxyl radical generation by normal polymorphonuclear leukocytes incubated in sera from patients with leukocytoclastic vasculitis.
Topics: Adult; Antigen-Antibody Complex; Dapsone; Female; Free Radicals; Humans; In Vitro Techniques; Male; | 1982 |
Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels.
Topics: Adult; Complement System Proteins; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Urticaria | 1981 |
Malignant pyoderma: a clinical variant of pyoderma gangrenosum.
Topics: Adrenal Cortex Hormones; Adult; Clofazimine; Dapsone; Female; Folliculitis; Humans; Pyoderma Gangren | 1996 |
Erythema elevatum diutinum complicated by rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dapsone; E | 1999 |
Hypocomplementemic urticarial vasculitis: report of a pediatric case.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Child; Complement System Proteins; Dapsone; Fema | 2000 |
Crohn's disease presenting with Henoch-Schönlein purpura.
Topics: Adolescent; Biopsy; Blood Vessels; Colon; Complement C3; Crohn Disease; Dapsone; Endoscopy, Gastroin | 2000 |
Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blister; Dapsone; Diagnosis, Differential; Female; Hand; Hu | 2000 |
Relapsing polychondritis and erythema elevatum diutinum: an unusual association refractory to dapsone.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Female; Humans; Polychondritis, Relapsing; | 2001 |
Lichenoid vasculitis associated with myeloproliferative disorder: successful treatment with dapsone.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Humans; Leg Dermatoses; Lic | 2001 |
Neutrophilic dermatosis (pustular vasculitis) of the dorsal hands: a report of 7 cases and review of the literature.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Fe | 2002 |
Erythema elevatum diutinum.
Topics: Aged; Arthritis, Rheumatoid; Dapsone; Erythema; Humans; Leg Ulcer; Male; Prednisone; Skin Diseases; | 1978 |
Necrotizing mesenteric vasculitis after longstanding cutaneous polyarteritis nodosa.
Topics: Adult; Azathioprine; Cyclophosphamide; Dapsone; Female; Humans; Mesenteric Arteries; Methotrexate; N | 1992 |
[Gastrointestinal involvement and the response to dapsone in a case of the urticarial vasculitis syndrome].
Topics: Adult; Chronic Disease; Dapsone; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Human | 1991 |
Chronic subcorneal pustulosis with vasculitis: a variant of generalized pustular psoriasis in black South Africans.
Topics: Adult; Black People; Child; Dapsone; Female; Humans; Middle Aged; Prednisolone; Psoriasis; Retrospec | 1991 |
[Disulone: focus on its indications in dermatology].
Topics: Dapsone; Granuloma; Humans; Lichen Planus; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Syst | 1990 |
Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
Topics: Administration, Oral; Adult; Complement C2; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous; | 1990 |
[Urticaria-vasculitis with bullous eruptions in visceral lupus erythematosus].
Topics: Adult; Antigen-Antibody Complex; Biopsy; Dapsone; Drug Therapy, Combination; Female; Fluorescent Ant | 1987 |
Dapsone and rheumatoid vasculitis leg ulcerations.
Topics: Adult; Aged; Arthritis, Rheumatoid; Dapsone; Female; Humans; Leg Ulcer; Vasculitis | 1988 |
Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases.
Topics: Adolescent; Blood Vessels; Dapsone; Female; Humans; IgA Vasculitis; Middle Aged; Skin; Vasculitis | 1987 |
Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone.
Topics: Arthritis; Complement System Proteins; Dapsone; Female; Glomerulonephritis; Humans; Kidney Glomerulu | 1986 |
[Toxic methemoglobinemia following the postoperative ingestion of 4,4-diaminodiphenylsulfone (DADPS)--on the differential diagnosis of cyanosis].
Topics: Adult; Cyanosis; Dapsone; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Me | 1985 |
Treatment of vasculitis with chlorpromazine and dapsone.
Topics: Chlorpromazine; Complement C3; Dapsone; Female; Humans; Immunoglobulin A; Middle Aged; Vasculitis | 1985 |
Urticarial vasculitis: response to dapsone and colchicine.
Topics: Colchicine; Dapsone; Female; Humans; Middle Aged; Urticaria; Vasculitis | 1985 |